医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
TENX · TENAX THERAPEUTICS, INC.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
TENAX THERAPEUTICS, INC.（TENX）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 $6.4M、卖出 —；高管董事有效买入 $133K、有效卖出 —。最近申报 2026-10-21。
买入 Bought$6.4M
卖出 Sold—
有效买入 Effective bought$133K
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-19 | ADAR1 Capital Management, LLC 10% Owner | 买入 Buy | 922,849 | $1.59 | $1.5M | SEC |
| 2026-09-16 | Doogan Declan Director | 买入 Buy · 有效 | 53,000 | $1.92 | $102K | SEC |
| 2026-09-11 | Giordano Christopher Thomas CEO, Director | 买入 Buy · 有效 | 10,850 | $1.85 | $20K | SEC |
| 2026-09-11 | STAAB THOMAS R II Chief Financial Officer | 买入 Buy · 有效 | 5,675 | $1.93 | $11K | SEC |
| 2026-09-03 | ADAR1 Capital Management, LLC 10% Owner | 买入 Buy | 900,000 | $1.78 | $1.6M | SEC |
| 2026-08-31 | ADAR1 Capital Management, LLC 10% Owner | 买入 Buy | 770,333 | $1.79 | $1.4M | SEC |
| 2026-08-20 | ADAR1 Capital Management, LLC 10% Owner | 买入 Buy | 1,025,867 | $1.77 | $1.8M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
内部人 Insiders
ADAR1 Capital Management, LLC、Doogan Declan、Giordano Christopher Thomas、STAAB THOMAS R II